Search results for " trials"

showing 10 items of 932 documents

Group treatment for substance use disorder in adults: A systematic review and meta-analysis of randomized-controlled trials

2019

Abstract Background and aims From residential programs to outpatient services, group therapy permeates the clinical field of substance misuse. While several group interventions for substance use disorders (SUDs) have demonstrated effectiveness, the existing evidence on group therapy has not been systematically reviewed. The current meta-analysis aims to provide estimates of the efficacy of group therapy for SUDs in adults using rigorous methods. Methods We included studies comparing group psychotherapy to no treatment control groups, individual psychotherapy, medication, self-help groups, and other active treatments applying no specific psychotherapeutic techniques for patients with substan…

AdultSubstance-Related Disordersmedicine.medical_treatmentmedia_common.quotation_subjectPsychological intervention030508 substance abuseMedicine (miscellaneous)AnxietySubstance use disorderlaw.inventionGroup psychotherapy03 medical and health sciences0302 clinical medicineRandomized controlled trialGroup psychotherapylawSettore M-PSI/07 - Psicologia DinamicamedicineHumans030212 general & internal medicineRandomized Controlled Trials as Topicmedia_commonAbstinenceDepressionbusiness.industryAbstinencemedicine.diseaseDrug AbstinenceSubstance abuseSelf-Help GroupsMeta-analysisPsychiatry and Mental healthClinical PsychologyMeta-analysisPsychotherapy GroupSystematic reviewAnxietyPshychiatric Mental Healthmedicine.symptom0305 other medical sciencebusinessClinical psychologyJournal of Substance Abuse Treatment
researchProduct

Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy?

2015

To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the first surgical assessment was performed.Retrospective analysis of primary AEOC patients was performed and three groups were formed based on where the decision of primary treatment was taken: Internal, if the decision was carried out at our Institution (PDS (Primary Debulking Surgery), I-IDS (Internal-Interval Debulking Surgery)) and Referred in case women were referred after neoadjuvant chemotherapy (NACT) from other Centers (R-IDS (Referred-Interval Debulking Surgery)).Among 573 AEOC, 279 (48.7%) were PDS and 294 (51.3%) IDS. In particular, 134 of 294 (45.6%) were R-IDS and 160 (54.4%) were I-IDS.…

AdultTertiary Care CenterCarcinoma Ovarian EpithelialDisease-Free SurvivalcytoreductionTertiary Care CentersOvarian cancerAntineoplastic Combined Chemotherapy ProtocolsHumansNeoplasms Glandular and EpithelialAgedNeoplasm StagingAged 80 and overOvarian NeoplasmsCytoreduction; Interval debulking surgery; Ovarian cancer; PrognosisClinical Trials as TopicAntineoplastic Combined Chemotherapy ProtocolOvarian NeoplasmMiddle AgedPrognosisNeoadjuvant TherapySettore MED/40 - GINECOLOGIA E OSTETRICIAinterval debulking surgeryFemaleprognosineoadjuvant chemotherapyHuman
researchProduct

Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model

2003

The reduced antigen content diphtheria, tetanus and pertussis (dTpa) vaccine (Boostrixtrade mark) has been shown to induce a strong booster response to all the vaccine components in 4-6 year olds. However, anti-diphtheria antibody levels were observed to be lower when compared to the "full strength" paediatric DTPa vaccine. To assess the impact of this difference on long-term protection, a mathematical model was developed to predict diphtheria antibody decay over time. The model was based on a linear decrease in log-transformed antibody concentrations after the first year post-vaccination. When applied to data collected 3.5 years after vaccination of 4-6 year olds with either DTPa or dTpa, …

AdultTime Factorsanimal diseasesImmunization SecondaryModels Biologicalcomplex mixturesCohort StudiesAntigenmedicineHumansChildDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleRandomized Controlled Trials as TopicBooster (rocketry)General VeterinaryGeneral Immunology and MicrobiologybiologyTetanusbusiness.industryDiphtheriaVaccinationPublic Health Environmental and Occupational HealthDiphtheriarespiratory systemmedicine.diseaseAntibodies BacterialVaccinationInfectious DiseasesImmunizationChild PreschoolImmunologycardiovascular systembiology.proteinMolecular MedicineAntibodybusinessDiphtheria antibodycirculatory and respiratory physiologyVaccine
researchProduct

Analysis of Safety and Tolerability Data Obtained from Over 1,500 Patients Receiving Topiramate for Migraine Prevention in Controlled Trials

2008

Objective.  Topiramate is an effective and generally well-tolerated migraine preventive therapy, as shown in three large, randomized, double-blind, placebo-controlled registration trials. Based upon efficacy/tolerability, topiramate 100 mg/day (50 mg BID) is the recommended target dose for most patients with migraine. To further assess the safety and tolerability of topiramate for migraine prevention, we analyzed safety data from 1,580 patients who participated in the three pivotal registration trials or an earlier pilot, randomized, double-blind, placebo-controlled trial. Methods.  The safety population consisted of all patients who took ≥1 dose of study medication during the double-blind …

AdultTopiramateAdolescentNauseaMigraine DisordersPopulationPhysical examinationFructosePlaceboTopiramatemedicineHumansChildAdverse effecteducationAgedRandomized Controlled Trials as Topiceducation.field_of_studymedicine.diagnostic_testbusiness.industryPatient SelectionDrug ToleranceGeneral MedicineMiddle Agedmedicine.diseaseNeuroprotective AgentsAnesthesiology and Pain MedicineTolerabilityMigraineAnesthesiaNeurology (clinical)Safetymedicine.symptombusinessmedicine.drugPain Medicine
researchProduct

Types of Adult Attention-Deficit/Hyperactivity Disorder: A Replication Analysis.

2019

OBJECTIVE Research supports the importance of emotional symptoms in adults with attention-deficit/hyperactivity disorder (ADHD), which are not reflected in the DSM-5 or ICD-10 criteria. The Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS) assesses these symptoms, plus inattention, hyperactivity, and impulsivity. This scale allowed us to divide adult ADHD into 2 subtypes in a 2015 publication: ADHD inattentive presentation and ADHD emotional dysregulation presentation. The present study refines this observation using a larger, more diverse sample. METHODS Eight double-blind adult ADHD clinical trials (encompassing 1,490 subjects) were selected because they included assessment…

AdultTreatment responseImpulsivityFactor structurebehavioral disciplines and activities03 medical and health sciences0302 clinical medicineRating scalemental disordersMedicineAttention deficit hyperactivity disorderHumansAffective SymptomsClinical Trials as Topicbusiness.industryAttention deficit disordermedicine.diseaseEmotional dysregulation030227 psychiatryClinical trialPsychiatry and Mental healthAttention Deficit Disorder with Hyperactivitymedicine.symptombusinessFactor Analysis Statistical030217 neurology & neurosurgeryClinical psychologyThe Journal of clinical psychiatry
researchProduct

Evidence of bias in randomized clinical trials of hepatitis C interferon therapies

2017

Introduction: Bias may occur in randomized clinical trials in favor of the new experimental treatment because of unblinded assessment of subjective endpoints or wish bias. Using results from published trials, we analyzed and compared the treatment effect of hepatitis C antiviral interferon therapies experimental or control. Methods: Meta-regression of trials enrolling naïve hepatitis C virus patients that underwent four therapies including interferon alone or plus ribavirin during past years. The outcome measure was the sustained response evaluated by transaminases and/or hepatitis C virus-RNA serum load. Data on the outcome across therapies were collected according to the assigned arm (exp…

Adultmedicine.medical_specialtyAlternative medicineAntiviral Agentslaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialBiaslawInterferonInternal medicinemedicineHumans030212 general & internal medicineSettore SECS-S/05 - Statistica SocialeRandomized Controlled Trials as TopicPharmacologyObserver Variationbusiness.industryGeneral MedicineHepatitis CMiddle Agedmedicine.diseaseHepatitis Cinterferon randomized controlled trials bias trial design favore armTreatment OutcomeResearch Design030220 oncology & carcinogenesisCase-Control StudiesPhysical therapyInterferonsbusinessmedicine.drug
researchProduct

Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients

2016

Background Invasive fungal infections are important causes of morbidity and mortality among critically ill patients. Early institution of antifungal therapy is pivotal for mortality reduction. Starting a targeted antifungal therapy after culture positivity and fungi identification requires a long time. Therefore, alternative strategies (globally defined as 'untargeted antifungal treatments') for antifungal therapy institution in patients without proven microbiological evidence of fungal infections have been discussed by international guidelines. This review was originally published in 2006 and updated in 2016. This updated review provides additional evidence for the clinician dealing with s…

Adultmedicine.medical_specialtyAntifungal drugMycoseintensive care medicinelaw.invention03 medical and health sciencesImmunocompromised Hostcritically ill patient0302 clinical medicineRandomized controlled triallawInternal medicineAmphotericin BmedicineHumansAntifungal AgentPharmacology (medical)030212 general & internal medicineMED/41 - ANESTESIOLOGIAIntensive care medicineFluconazoleFluconazole [therapeutic use]Randomized Controlled Trials as Topicbusiness.industryfungal infectionMicafungin030208 emergency & critical care medicinePublication biasMycoses [mortalityClinical trialCritical Illness [mortality]; Amphotericin B [therapeutic use]; Antifungal Agents [therapeutic use]; Fluconazole [therapeutic use]; Immunocompromised Host; Mycoses [mortality; prevention & control]; Randomized Controlled Trials as Topic; Adult; HumansAntifungal Agents [therapeutic use]prevention & control]Relative riskMeta-analysisAmphotericin B [therapeutic use]AnidulafunginCritical IllneCritical Illness [mortality]businessmedicine.drugHuman
researchProduct

Femtosecond laser versus mechanical microkeratome laser in situ keratomileusis for myopia: Metaanalysis of randomized controlled trials.

2011

Purpose To examine differences in efficacy, accuracy, safety, and changes in aberrations between femtosecond and mechanical microkeratome laser in situ keratomileusis (LASIK) for myopia. Setting Department of Ophthalmology, Shanghai First People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China. Design Evidence-based manuscript. Methods Data sources, including PubMed, Medline, EMBASE, and Cochrane Controlled Trials Register, were searched to identify potentially relevant prospective randomized controlled trials. Primary outcome measures were efficacy (uncorrected distance visual acuity ≥20/20), accuracy (±0.50 diopter mean spherical equivalent), and safety (loss of ≥2 l…

Adultmedicine.medical_specialtyCorneal Wavefront Aberrationgenetic structuresDatabases Factualmedicine.medical_treatmentCorneal StromaKeratomileusis Laser In SituVisual AcuityKeratomileusisRefraction OcularSensitivity and Specificitylaw.inventionYoung AdultPostoperative ComplicationsRandomized controlled triallawMicrokeratomemedicineMyopiaHumansRegistriesDioptreRandomized Controlled Trials as TopicEquipment Safetybusiness.industryLASIKReproducibility of ResultsOdds ratioMiddle Agedeye diseasesSensory SystemsConfidence intervalSurgeryOphthalmologyTreatment OutcomeMeta-analysisSurgeryLasers ExcimerbusinessJournal of cataract and refractive surgery
researchProduct

Family perceptions of clinical research and the informed consent process in the ICU

2020

Abstract Purpose We investigated experiences of families who provide consent for research on behalf of a loved-one hospitalized in intensive care (ICU). Methods Multicentre, qualitative, descriptive study using semi-directive interviews in 3 ICUs. Eligible relatives were aged >18 years, and had provided informed consent for a clinical trial on behalf of a patient hospitalized in ICU. Interviews were conducted from 06/2018 to 06/2019 by a qualified sociologist, recorded and transcribed. Results Fifteen relatives were interviewed; average age 50.3 ± 15 years. All emphasized their interest in clinical research, seeing it as a duty. Involving their loved-one in research allowed them to find mea…

Adultmedicine.medical_specialtyCritical Caremedia_common.quotation_subjectCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicineInformed consentPhysiciansIntensive careHumansMedicineFamilyDutyQualitative ResearchAgedmedia_commonClinical Trials as TopicInformed Consentbusiness.industryInformation quality030208 emergency & critical care medicineMiddle AgedClinical trialIntensive Care UnitsClinical researchCaregivers030228 respiratory systemFamily medicineDescriptive researchbusinessQualitative researchJournal of Critical Care
researchProduct

Effectiveness and safety of once-daily aminoglycosides: A meta-analysis

1996

The effectiveness and safety of once-daily versus several-times-daily aminoglycosides were studied in a meta-analysis. MEDLINE for 1988 to 1995 was searched, and additional studies were identified from review articles and references in retrieved articles. Studies selected for meta-analysis were randomized controlled clinical trials in nonneutropenic adult patients comparing the clinical effectiveness or nephrotoxicity or ototoxicity of once-daily with several-times-daily aminoglycosides. Differences between groups were expressed as odds ratios. The results were combined by the procedure of Mantel and Haenszel, and 95% confidence intervals and exact confidence intervals were computed. An odd…

Adultmedicine.medical_specialtyMEDLINEInfectionsDrug Administration ScheduleNephrotoxicityOtotoxicityInternal medicinemedicineHumansNetilmicinEar DiseasesAmikacinAgedAntibacterial agentPharmacologybusiness.industryHealth PolicyOdds ratioMiddle Agedmedicine.diseaseConfidence intervalAnti-Bacterial AgentsSurgeryClinical trialMeta-analysisKidney DiseasesControlled Clinical Trials as TopicGentamicinsbusinessAmerican Journal of Health-System Pharmacy
researchProduct